Modeling early Epstein-Barr virus infection in Drosophila melanogaster: The BZLF1 protein

Genetics

Volumn 171, Issue 3, 2005, Pages 1125-1135

  Adamson, Amy L ^a   Wright, Natasha ^a   LaJeunesse, Dennis R ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN BZLF1; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PAX8; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; EPSTEIN BARR VIRUS; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; VIRUS INFECTION;

ANIMALS; APOPTOSIS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EPSTEIN-BARR VIRUS INFECTIONS; EYE; EYE PROTEINS; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; LARVA; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHOTORECEPTORS; TRANS-ACTIVATORS; VIRAL PROTEINS;

ANIMALIA; DROSOPHILA MELANOGASTER; HUMAN HERPESVIRUS 4;

EID: 32544452682     PISSN: 00166731     EISSN: None     Source Type: Journal    
DOI: 10.1534/genetics.105.042572     Document Type: Article

References (56)

1. ADAMSON, A. L., 2005 The Epstein-Barr virus BZLF1 protein associates with mitotic chromosomes. J. Virol. 79: 7899-7904.
2. ADAMSON, A. L., and S. KENNEY, 1999 The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J. Virol. 73: 6551-6558.
3. ADAMSON, A., and S. KENNEY, 2001 The Epstein-Barr Virus (EBV) immediate-early protein, BZLF1, is SUMO-1-modified and disrupts PML bodies. J. Virol. 75: 2388-2399.
4. ADAMSON, A., D. DARR, E. HOLLEY-GUTHRIE, R. A. JOHNSON, A. MAUSER et al., 2000 Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J. Virol. 74: 1224-1233.
5. BABCOCK, G. J., L. L. DECKER, M. VOLK and D. A. THORLEY-LAWSON, 1998 EBV persistence in memory B cells in vivo. Immunity 9: 395-404.
6. BAKER, S. J., and E. P. REDDY, 1995 B cell differentiation: role of E2A and Pax5/BSAP transcription factors. Oncogene 11: 413-426.
7. BERNARDS, A., and I. K. HARIHARAN, 2001 Of flies and men - studying human disease in Drosophila. Curr. Opin. Genet. Dev. 11: 274-278.
8. BIER, E., 2005 Drosophila, the golden bug, emerges as a tool for human genetics. Nat. Rev. Genet. 6: 9-23.
9. BLOCHLINGER, K., L. Y. JAN and Y. N. JAN, 1993 Postembryonic patterns of expression of cut, a locus regulating sensory organ identity in Drosophila. Development 117: 441-450.
10. BONINI, N. M., 2001 Drosophila as a genetic approach to human neurodegenerative disease. Parkinsonism Relat. Disord. 7: 171-175.
11. BONINI, N. M., and M. E. FORTINI, 2003 Human neurodegenerative disease modeling using Drosophila. Annu. Rev. Neurosci. 26: 627-656.
12. CALAME, K. L., K. I. LIN and C. TUNYAPLIN, 2003 Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21: 205-230.
13. CAYROL, C., and E. FLEMINGTON, 1996a G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta. J. Biol. Chem. 271: 31799-31802.
14. CAYROL, C., and E. FLEMINGTON, 1996b The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15: 2748-2759.
15. CHEVALLIER-GRECO, A., E. MANET, P. CHAVRIER, C. MOSNIER, J. DAILLIE et al., 1986 Both Epstein-Barr virus (EBV) encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an early EBV promoter. EMBO J. 5: 3243-3249.
16. CHI, N., and J. A. EPSTEIN, 2002 Getting your Pax straight: Pax proteins in development and disease. Trends Genet. 18: 41-47.
17. COX, M., J. LEAHY and J. M. HARDWICK, 1990 An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J. Virol. 64: 313-321.
18. DE NOOIJ, J. C., M. A. LETENDRE and I. K. HARIHARAN, 1996 A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell 87: 1237-1247.
19. DU, W., M. VIDAL, J. E. XIE and N. DYSON, 1996 RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. Genes Dev. 10: 1206-1218.
20. EDGAR, B., and C. LEHNER, 1996 Developmental control of cell cycle regulators: a fly's perspective. Science 274: 1646-1652.
21. ENVER, T., 1999 B-cell commitment: Pax5 is the deciding factor. Curr. Biol. 9: R933-R935.
22. FARRELL, P., D. ROWE, C. ROONEY and T. KOUZARIDES, 1989 Epstein-Barr virus BZLF1 trans-activator specifically binds to consensus Ap1 site and is related to c-fos. EMBO J. 8: 127-132.
23. FU, W., and M. NOLL, 1997 The Pax2 homolog sparkling is required for development of cone and pigment cells in the Drosophila eye. Genes Dev. 11: 2066-2078.
24. FU, W., H. DUAN, E. FREI and M. NOLL, 1998 shaven and sparkling are mutations in separate enhancers of the Drosophila Pax2 homolog. Development 125: 2943-2950.
25. GARNER, M., and A. REVZIN, 1981 A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res. 9: 3047-3060.
26. GIOT, J.-F., I. MIKAELIAN, M. BUISSON, E. MANET, I. JOAB et al., 1991 Transcriptional synergy and interference between the EBV transcription factors EB1 and R require both the basic region and the activation domains of EB1. Nucleic Acids Res. 19: 1251-1258.
27. GORMAN, C., L. MOFFAT and B. HOWARD, 1982 Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol. Cell. Biol. 2: 1044-1051.
28. GUTSCH, D. E., E. A. HOLLEY-GUTHRIE, Q. ZHANG, B. STEIN, M. A. BLANAR et al., 1994 The bZIP transactivator, BZLF1, of Epstein-Barr virus functionally and physically interacts with the p65 subunit of NFkB. Mol. Cell. Biol. 14: 139-149.
29. HAY, B. A., T. WOLFF and G. RUBIN, 1994 Expression of baculovirus P35 prevents cell death in Drosophila. Development 120: 2121-2129.
30. HOLLEY-GUTHRIE, E., E. QUINLIVAN, E. MAR and S. KENNEY, 1990 The Epstein-Barr virus promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell specific manner. J. Virol. 64: 3753-3759.
31. KENNEY, S., E. HOLLEY-GUTHRIE, E.-C. MAR and M. SMITH, 1989 The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J. Virol. 63: 3878-3883.
32. KIEFF, E., and A. B. RICKINSON, 2001 Epstein-Barr virus and its replication, pp. 2511-2573 in Fields Virology, Ed. 4, edited by D. M. KNIPE, P. M. HOWLEY, D. E. GRIFFIN, R. A. LAMB, M. A. MARTIN et al. Lippincott Williams & Wilkins, Philadelphia.
33. LAJEUNESSE, D. R., B. M. MCCARTNEY and R. G. FEHON, 1998 Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization. J. Cell Biol. 141: 1589-1599.
34. LAJEUNESSE, D. R., B. M. MCCARTNEY and R. G. FEHON, 2001 A systematic screen for dominant second-site modifiers of Merlin/NF2 phenotypes reveals an interaction with blistered/DSRF and scribbler. Genetics 158: 893-904.
35. LAJEUNESSE, D. R., K. BROOKS and A. L. ADAMSON, 2005 Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication. Biochem. Biophys. Res. Commun. 333: 438-442.
36. MAUSER, A, E. HOLLEY-GUTHRIE, D. SIMPSON, W. KAUFMANN and S. KENNEY, 2002a The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block. J. Virol. 76: 10030-10037.
37. MAUSER, A., S. SAITO, E. APPELLA, C. W. ANDERSON, W. T. SEAMAN et al., 2002b The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J. Virol. 76: 12503-12512.
38. MIKKOLA, I., B. HEAVEY, M. HORCHER and M. BUSSLINGER, 2002 Reversion of B cell commitment upon loss of Pax5 expression. Science 297: 110-113.
39. MORRISON, T. E., and S. C. KENNEY, 2004 BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function. Virology 328: 219-232.
40. NIEDOBITEK, G., A. AGATHANGGELOU, H. HERBST, L. WHITEHEAD, D. H. WRIGHT et al., 1997 Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J. Pathol. 182: 151-159.
41. QUINLIVAN, E., E. HOLLEY-GUTHRIE, M. NORRIS, D. GUTSCH, S. BACHENHEIMER et al., 1993 Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res. 21: 1999-2007.
42. REBAY, I., R. G. FEHON and S. ARTAVANIS-TSAKONAS, 1993 Specific truncations of Drosophila Notch define dominant activated and dominant negative forms of the receptor. Cell 74: 319-329.
43. REBAY, I., F. CHEN, F. HSIAO, P. A KOLODZIEJ, B. H. KUANG et al., 2000 A genetic screen for novel components of the Ras/mitogen-activated protein kinase signaling pathway that interact with the yan gene of Drosophila identifies split ends, a new RNA recognition motif-containing protein. Genetics 154: 695-712.
44. RICKINSON, A. B., and E. KIEFF, 2001 Epstein-Barr virus, pp. 2575-2627 in Fields Virology, Ed. 4, edited by D. M. KNIPE, P. M. HOWLEY, D. E. GRIFFIN, R. A. LAMB, M. A. MARTIN et al. Lippincott Williams & Wilkin, Philadelphia.
45. ROBINOW, S., and K. WHITE, 1988 The locus elav of Drosophila melanogaster is expressed in neurons at all developmental stages. Dev. Biol. 126: 294-303.
46. SAMBROOK, J., E. F. FRITSCH and T. MANIATIS, 1989 Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
47. SCHREITER, K., A. STEUERNAGEL, B. RUDOLPH, D. RUDOLPH, R. WEHR et al., 2004 DG175 - an inner mitrochondrial transmembrane protein identified in a UCP-modifier screen in Drosophila. Obes. Res. 12: 171.
48. SIDDALL, N. A., K. J. BEHAN, J. R. CREW, T. L. CHEUNG, J. A. FAIR et al., 2003 Mutations in lozenge and D-Pax2 invoke ectopic patterned cell death in the developing Drosophila eye using distinct mechanisms. Dev. Genes Evol. 213: 107-119.
49. SINCLAIR, A. J., 2003 bZIP proteins of human gammaherpesviruses. J. Gen. Virol. 84: 1941-1949.
50. TIERNEY, R. J., H. E. KIRBY, J. K. NAGRA, J. DESMOND, A. I. BELL et al., 2000a Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation. J. Virol. 74: 10468-10479.
51. TIERNEY, R., H. KIRBY, J. NAGRA, A. RICKINSON and A. BELL, 2000b The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5. J. Virol. 74: 10458-10467.
52. URBANEK, P., Z. Q. WANG, I. FETKA, E. F. WAGNER and M. BUSSLINGER, 1994 Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79: 901-912.
53. URIER, G., M. BUISSON, P. CHAMBARD and A. SERGEANT, 1989 The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. EMBO J. 8: 1447-1453.
54. WOLFF, T., 2000 Histological techniques for the Drosophila eye, part I: larva and pupa, pp. 201-227 in Drosophila Protocols, edited by W. Sullivan, M. Ashburner and R. S. Hawley. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
55. ZHANG, Q., D. GUTSCH and S. KENNEY, 1994 Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell. Biol. 14: 1929-1938.
56. ZUR HAUSEN, H., H. SCHULTE-HOLTHAUZEN, G. KLEIN, G. HENLE, W. HENLE et al., 1970 EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 1956-1958.